Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Buy
69,531
+23,546
+51% +$521K ﹤0.01% 7261
2026
Q1
$1.07M Buy
45,985
+40,915
+807% +$1.27M ﹤0.01% 7714
2025
Q4
$225K Buy
+5,070
New +$285K ﹤0.01% 10620
2025
Q3
Sell
-10,091
Closed -$658K 12674
2025
Q2
$619K Buy
10,091
+4,391
+77% +$245K ﹤0.01% 8675
2025
Q1
$331K Sell
5,700
-2,785
-33% -$176K ﹤0.01% 9856
2024
Q4
$453K Buy
8,485
+3,459
+69% +$169K ﹤0.01% 8923
2024
Q3
$219K Buy
+5,026
New +$168K ﹤0.01% 10282
2024
Q1
Sell
-29,007
Closed -$827K 12397
2023
Q4
$813K Buy
+29,007
New +$685K ﹤0.01% 7491
2023
Q3
Sell
-142,468
Closed -$3.89M 12184
2023
Q2
$4.85M Sell
142,468
-138,442
-49% -$4.61M ﹤0.01% 3586
2023
Q1
$9.1M Buy
280,910
+185,915
+196% +$6.17M ﹤0.01% 2585
2022
Q4
$3.19M Buy
+94,995
New +$2.9M ﹤0.01% 3914
2022
Q2
Sell
-102,708
Closed -$4.04M 13081
2022
Q1
$5.35M Buy
102,708
+34,617
+51% +$1.74M ﹤0.01% 3528
2021
Q4
$3.41M Buy
68,091
+1,692
+3% +$110K ﹤0.01% 4429
2021
Q3
$5.36M Buy
+66,399
New +$4.86M ﹤0.01% 3830

Other funds holding DOCS

Jeff Yass's DOCS Position: Q2 2026 in Review

Jeff Yass increased its Doximity (DOCS) stake by 51% in Q2 2026, buying an estimated $521K and bringing the position to 69,531 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #7261.

Jeff Yass first reported a position in DOCS in Q3 2021 and has held it in 14 quarters since. The position peaked at $9.1M in Q1 2023. 356 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Jeff Yass held 69,531 shares of Doximity worth $1.44M as of Q2 2026.
  • Jeff Yass bought 23,546 Doximity shares in Q2 2026, an estimated $521K.
  • Doximity made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7261 holding.
  • Jeff Yass first reported a position in Doximity in Q3 2021 and has held it in 14 quarters since.
  • Jeff Yass's Doximity position peaked at $9.1M in Q1 2023.
  • 356 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.